Studying blood proteins in people with colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study looks at whether two proteins, talin-1 and cripto-1, can be detected in the blood of people with colorectal cancer. It aims to understand if these proteins could help diagnose or monitor the disease in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years.
- You have symptoms of colorectal cancer, such as changes in bowel habits, constipation, rectal bleeding, weight loss, or bowel blockage.
- Your cancer diagnosis has been confirmed by imaging (like a CT scan) and a biopsy.
- You have not yet received chemotherapy or had surgery to remove the cancer.
- You do not have familial adenomatous polyposis (a genetic condition causing many polyps), hereditary non-polyposis colorectal cancer (a genetic condition increasing colon cancer risk), or inflammatory bowel disease, and you have not had any other type of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test that might help detect colorectal cancer. If you're already planning a colonoscopy or colorectal surgery, your participation could help improve early detection.
This study checks whether a blood test can help identify colorectal cancer or precancerous growths. You would have a planned colonoscopy, and researchers compare the blood test results to what the colonoscopy finds.
This research study uses a blood test to look for signs of colorectal cancer in people who have other types of cancer or digestive diseases. The goal is to see if the test can correctly tell the difference between colorectal cancer and other conditions.
This study looks at special tiny cell-signal particles (called exosomes) and related pathways to understand colorectal cancer. Your results from samples may help researchers learn how these signals relate to the disease after surgery.
This study looks for early signs of colorectal cancer and ways to check if it comes back after treatment. It uses blood samples to find markers that could help doctors diagnose and monitor the disease more effectively.
This study looks at colorectal cancer patients who are planning curative surgery and collects related outcomes and lab “biomarker” information to better understand the disease. Your participation may help researchers connect test results to treatment results over time.
Hear when a new Colo-rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.